UAB "Pharm House" Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 1,663,572 |
| 308,640 |
| 492,536 |
| 419,560 |
| 77,840 |
| 45.23 |
| 25.22 |
| 589,658 |
| 172,857 |
| 69,034 |
| 689,824 |
| 2024 |
|---|
| 2,203,946 |
| 367,324 |
| 635,235 |
| 539,645 |
| 89,941 |
| 53.80 |
| 24.49 |
| 894,008 |
| 513,615 |
| 198,056 |
| 1,199,435 |
| 2025 |
|---|
| 2,344,838 |
| 390,806 |
| 633,506 |
| 532,649 |
| 88,775 |
| 50.86 |
| 22.72 |
| 1,073,716 |
| 371,700 |
| 198,936 |
| 1,236,494 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 2,344,838 |
| 390,806 |
| 633,506 |
| 532,649 |
| 88,775 |
| 50.86 |
| 22.72 |
| 1,073,716 |
| 371,700 |
| 198,936 |
| 1,236,494 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
2,344,838 €6 % *
Sales per employee (€)
390,806 €6 % *
Profit before tax (€)
633,506 €0 % *
Net Profit (€)
532,649 €-1 % *
Profit per employee (€)
88,775 €-1 % *
Total profitability (%)
50.86 %-5.46 % *
Net profitability (%)
22.72 %-7.23 % *
Equity (€)
1,073,716 €20 % *
Amounts Payable And Liabilities (€)
371,700 €-28 % *
Non-current Assets (€)
198,936 €0 % *
CurrentAssets (€)
1,236,494 €3 % *
